In 2011, the management of Novozymes, the industry leader of enzymes affect the viability of their position in the fast-growing but increasingly competitive Chinese market. Novozymes, a pioneer of technological innovation, has a prominent place in the premium markets of China enzyme, but felt pressure from local low-cost competitors in volume driven, commoditized segment. Novozymes as related to local competitors? By competing on technological innovation only in the high-margin vertical? Or through a separate subsidiary, a new low-cost business model for standardized products vertically? "Hide
by Krishna G. Palepu, Karol Misztal Source: Harvard Business School 22 pages. Publication Date: April 4, 2012. Prod. #: 112084-PDF-ENG
Related Case Solutions & Analyses:
SKII China: Managing Public Relations
Savage Beast (A)
Overcoming Corporate Rigidities in the Dynamic Chinese Market
Learning to Lead in China: Antonio Scarsi Takes Command
Automobile Retailing in the U.S.
Cooper Industries Corporate Strategy Video
North American Financial Corporation (NAF) The MLM Project (A)
Daqi Case Report
Mekong Capital
Maersk Group
